Intelligence in Medical Technologies is a Medical software company dedicated to Metrology on vascular structures

Our Products
Our Services

Neuro-Cardio Vascular diseases are the first cause of death in the world

People with Neuro-Cardio-Vascular disease or who are at high cardio neuro vascular risk need early detection and management using predictive and precision medicine, as appropriate. 

18M deaths per year in the world

€38 Bn costs /year in EU

Global costs to increase to €1,000 Bn by 2030

Our Vision

Primordial Prevention and 5P Medicine when it comes to Arterial Health, and focus on detecting undiagnosed Cardio Vascular risk factors in order to enable an early treatment  for those, before they may lead to a clinical event.

Arterial aging, worsened by traditional risk factors such as hypertension, hypercholesterolemia, diabetes and tobacco consumption is a natural process which may silently and progressively harm carotid, coronary and lower limbs arteries leading to atherosclerosis disease and neuro cardio vascular events.

Read more about it

Our Experience

For over 10 years we have been participating in large epidemiological and interventional trials, whether cross-sectional or prospective, gathering more than 25,000 patients in more than 600 centers across 25 countries.

Read more about it

Our Services and Products

M’AthCloud® & M’Ath®

With extensive experience in clinical trials, we have designed measurement tools for physicians and clinical studies, improving data acquisition, flow and management. We invite you to discover them on the page below.

Read More

Corelab activities for Clinical Trials

Sonographer certification is a major step in all the ultrasound studies. Our experience on training and certification is…

Read More

Regulatory information

M’Ath® and M’AthCloud® are Class I medical devices under Regulation (EU) 2017/745, intended for the measurement of carotid intima-media thickness and plaques on ultrasound images. They provide measurements and a metrological report; they do not deliver any diagnosis or therapeutic recommendation, and clinical interpretation remains the physician’s responsibility. EU Declaration of Conformity issued by the manufacturer IMT – Intelligence in Medical Technologies, Paris. M’Ath® has also received FDA 510(k) clearance in the United States.

Our clients

For all your inquiries or proposals, do not hesitate to write us here

partenaire 1
partenaire 3
Précédent
Suivant
Contact us now